Tetrahydrofuran
Sigma Aldrich Fine Chemicals Biosciences Tetrahydrofuran contains 250 ppm BHT as inhibitor, ACS reagent, >=99.0% | 109-99-9 | MFCD00005356 | 1L
Tetrahydrofuran contains 250 ppm BHT as inhibitor, ACS reagent, >=99.0% | Purity: >=99.0% | Mol Wt: 72.11 | 109-99-9 | MFCD00005356 | 1L
Medchemexpress LLC Bevurogant (BI 730357) | 1817773-66-2 | 99.5% | C26H28N8O3S | 10MG
Bevurogant (BI 730357) is a retinoid-related orphan receptor-gamma t (RORγt) antagonist supplied as a high-purity research compound for in vitro and preclinical studies of chronic inflammatory diseases.
- Retinoid-related orphan receptor-gamma t antagonist.
- High purity: 99.5%.
- Molecular formula: C26H28N8O3S.
- Offered as a 10 mg research quantity.
- Provided with chemical identifiers for research use.
Glen Research Tetrahydrofuran/Pyridine/Acetic Anhydride, 2000 mL, 0.2 micron filtered, Hazardous material: Yes
This Glen Research product is a high-purity blend of Tetrahydrofuran, Pyridine, and Acetic Anhydride supplied in a 2000 mL volume. It is prepared to exacting specifications for optimal performance in demanding scientific applications, particularly oligonucleotide synthesis. Processed through a 0.2 micron filter during packaging to minimize particulate contamination, this reagent is ideal for ensuring high synthesis efficiency.
- 2000 mL volume
- Primary components include Tetrahydrofuran, Pyridine, and Acetic Anhydride
- Application in oligonucleotide synthesis
- Processed through a 0.2 micron filter
- Prepared to exacting specifications
- Hazardous material
- Stored at controlled room temperature
Medchemexpress LLC Ralaniten triacetate | 1637573-04-6 | 98.8% | 521.00 | C27H33ClO8 | 25MG
Ralaniten triacetate is an orally active androgen receptor (AR) N-terminal domain (NTD) inhibitor used for preclinical research. It functions as a pro-agent of ralaniten, inhibiting AR transcriptional activity and showing activity against full-length and resistance-related AR species, including AR-v7. Consult the supplier documentation for handling, storage, purity, and safety information.
- First-in-class AR N-terminal domain inhibition.
- Active against full-length and resistant AR species such as AR-v7.
- Inhibits AR transcriptional activity.
- Suitable for research into castration-resistant prostate cancer models.
- Supplied with certificate of analysis and safety data sheet for quality verification.
Medchemexpress LLC Otaplimastat | 1176758-04-5 | 98.1% | 534.61 | 10 MG
Otaplimastat is a matrix metalloproteinase (MMP) inhibitor that competitively blocks N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity. It also demonstrates anti-oxidant activity and can be used for research on brain ischemic injury.
- Acts as an MMP inhibitor.
- Blocks NMDA receptor-mediated excitotoxicity in a competitive manner.
- Exhibits anti-oxidant activity.
- Can be used for the research of brain ischemic injury.
- For research use only.
Medchemexpress LLC Taurohyodeoxycholic 10mg | 386523 | 10 MG
Taurohyodeoxycholic acid is a taurine-conjugated 6α-hydroxylated bile acid used in biochemical and preclinical research to investigate liver and intestinal inflammation. It modulates inflammatory markers such as MPO, TNF-α, IL-6, and COX-2, and is applied in models of nonalcoholic fatty liver disease, colitis, and biliary disorders.
- Purity: 99.7%
- Molecular weight: 499.7 g·mol⁻¹
- Chemical formula: C26H45NO6S
- Available as small solid aliquots (for example 10 MG) and as DMSO solution (10 mM x 1 mL)
- Suitable for in vitro assays and in vivo disease models
- Datasheet and SDS available for handling and safety information
Medchemexpress LLC Nateglinide | 105816-04-4 | MFCD00875706 | 99.95% | 100 MG
Nateglinide is a D-phenylalanine derivative that acts as an orally active, short-acting insulinotropic agent and a DPP IV inhibitor. It functions by inhibiting ATP-sensitive K+ channels in pancreatic β-cells and is utilized in the treatment of type 2 (non-insulin-dependent) diabetes mellitus. This product is intended for research use only and is not sold to patients.
- Acts as an orally active, short-acting insulinotropic agent
- Functions as a DPP IV inhibitor
- Inhibits ATP-sensitive K+ channels in pancreatic β-cells
- Used for the treatment of type 2 diabetes mellitus
- Inhibits dinitrophenol-induced KATP currents
- Stimulates human C-peptide secretion
- Improves postprandial glucose concentrations
![Medchemexpress LLC 2-[[5-[(4-fluorophenyl)carbamoyl]pyrimidin-2-yl]sulfanylmethyl]-4-(trifluoromethoxy)phenyl boronic acid | 1648843-04-2 | 99.7% | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000234135.png-250.jpg)
Medchemexpress LLC 2-[[5-[(4-fluorophenyl)carbamoyl]pyrimidin-2-yl]sulfanylmethyl]-4-(trifluoromethoxy)phenyl boronic acid | 1648843-04-2 | 99.7% | 10 MG
SX-682 is an orally bioavailable small-molecule allosteric inhibitor of chemokine receptors CXCR1 and CXCR2 under clinical investigation for oncology indications; it blocks recruitment of myeloid-derived suppressor cells and can enhance T-cell activity.
- Orally bioavailable small-molecule CXCR1/2 inhibitor
- Blocks recruitment of myeloid-derived suppressor cells (MDSCs)
- Enhances T-cell activation and antitumor immune responses
- Demonstrated activity in preclinical tumor models and clinical trials
- Supplied with high purity (typical >99%) and available in small-mass packaging for research
Medchemexpress LLC Aprutumab 5mg | 5mg
Aprutumab (BAY 1179470) is a fully human FGFR2 monoclonal antibody which binds to the FGFR2 isoforms FGFR2-IIIb and FGFR2-IIIc Aprutumab has the potential for solid tumors research[1]
Medchemexpress LLC Vebicorvir (ABI-H0731) | 2090064-66-5 | 99.7% | 467.44 | 100 MG
Vebicorvir (ABI-H0731) is a first-generation hepatitis B virus (HBV) core protein inhibitor. It suppresses covalently closed circular DNA (cccDNA) formation in two de novo infection models with EC50s from 1.84 μM to 7.3 μM.
- Inhibits pgRNA, HBeAg, and HBsAg production, with EC50s of 2.68 μM, 4.95 μM, and 7.30 μM, respectively.
- Acts as an inhibitor of pgRNA encapsidation and rcDNA synthesis.
Medchemexpress LLC Pelcitoclax | 1619923-36-2 | 99.7% | 1281.85 | 10 MG
Pelcitoclax (APG-1252) is a potent Bcl-2/Bcl-xl inhibitor with antineoplastic and pro-apoptotic effects. It is for research use only. In vitro, APG-1252 changes to a reactive metabolite named APG-1252-M1, which has remarkable antitumor effects in acute myeloid leukemia. In vivo, Pelcitoclax (APG-1252) treatment inhibits xenograft tumor growth.
- Potent Bcl-2/Bcl-xl inhibitor
- Antineoplastic and pro-apoptotic effects
- Changes to reactive metabolite APG-1252-M1 with antitumor effects in acute myeloid leukemia
- Inhibits xenograft tumor growth in vivo
- Solid appearance
- White to off-white color
Medchemexpress LLC Broflanilide | 1207727-04-5 | 99.0% | 663.28 | 2 MG
Broflanilide is a potential insecticide that metabolizes to Desmethyl-Broflanilide. Desmethyl-Broflanilide is a potent antagonist at the insect resistant-to-dieldrin (RDL) GABA Receptor, inhibiting S. litura RDL GABAR with an IC50 value of 1.3 nM.
- It is a potential insecticide.
- It metabolizes into an active form, Desmethyl-Broflanilide.
- The metabolite, Desmethyl-Broflanilide, acts as a potent antagonist at the insect GABA Receptor.
- The metabolite demonstrates selective inhibition against S. litura RDL GABAR, with an IC50 of 1.3 nM.
- The metabolite exhibits weak activity against human and mammalian GABAA receptors and human glycine receptors.
Medchemexpress LLC Csf1r-in-1 | 2095849-04-8 | 98.0% | 479.45 g/mol | C25H20F3N5O2 | 10 MG
CSF1R-IN-1 is a potent small-molecule inhibitor of colony stimulating factor 1 receptor (CSF1R) with sub-nanomolar cellular potency. It is supplied for research use to probe CSF1R signaling, macrophage biology, and related disease models.
- Potent CSF1R inhibition with reported IC50 of 0.5 nM.
- High purity: 98.04%.
- Molecular formula C25H20F3N5O2 and molecular weight 479.45 g/mol.
- Available in powder and ready-to-use DMSO solutions; common pack sizes include 10 mg.
- Storage: powder at -20 °C; in solvent at -80 °C (up to 6 months) or -20 °C (up to 1 month).
- For research use only, not intended for human or veterinary use.
eMolecules AstaTech / 2-BROMOCYCLOPENTANOL / 0.1g / 718068659 / E84758 / 95.000 / 74305-04-7 / MFCD20622315 / 165.030 / C5H9BrO
AstaTech / 2-BROMOCYCLOPENTANOL / 0.1g / 718068659 / E84758 / 95.000 / 74305-04-7 / MFCD20622315 / 165.030 / C5H9BrO